S-Adenosylhomocysteine
|
Basic information |
| Metabolite name | S-Adenosylhomocysteine |
 | HMDB0000939 |
 |
C00021 |
 |
439155 |
| Synonyms | S-adenosyl-L-homocysteine; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | S-Adenosylhomocysteine |
| HMDB0000939 |
|
C00021 |
|
439155 |
| Synonyms | S-adenosyl-L-homocysteine; |
| No. of studies | 5 |
|
Relationship between S-Adenosylhomocysteine and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M1053 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M1053 | Type2 | CUMS + quercetin group vs. CUMS group | Liver | Sprague-Dawley rat | Down |
| Study M840 | Type1 | A1/A2 beta-casein group vs. control group | Frontal cortex | Wistar rat | Down |
| Study M912 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |